51 filings
Page 2 of 3
8-K
wim6f
30 Oct 23
Regulation FD Disclosure
8:05am
8-K
ywzpfld
24 Oct 23
Other Events
8:05am
8-K/A
ll8mw76o3v21ln3qs1a
19 Oct 23
Financial Statements and Exhibits
5:23pm
8-K
r7xzjm0 03w
5 Oct 23
Index to Financial Statements
5:12pm
8-K
s4ytgt24p rt169
29 Sep 23
Entry into a Material Definitive Agreement
5:24pm
8-K
ozi28
29 Sep 23
Submission of Matters to a Vote of Security Holders
3:11pm
8-K
mio5kmfybzvcko6rtf7
22 Sep 23
Entry into a Material Definitive Agreement
12:55pm
8-K
yn5u6ki 2mbyi
22 Sep 23
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting
9:26am
8-K
rf386kfyrt9gje4zpjc
19 Sep 23
Entry into a Material Definitive Agreement
3:51pm
8-K
wesfp
18 Sep 23
Entry into a Material Definitive Agreement
9:25am
8-K
7x010s
14 Sep 23
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting
9:30am
8-K
hgob761h7w
11 Sep 23
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting
11:30am
8-K
zta k9aqg0
30 Aug 23
Graf Acquisition Corp. IV Announces Intent to Adjourn Special Meeting
7:30am
8-K
xhdro
15 Aug 23
Graf Acquisition Corp. Iv and Nkgen Biotech, Inc. Announce Effectiveness of Form S-4 for Proposed Business Combination
4:30pm
8-K
5lfdg0rn6t
26 Jul 23
For Investor Use Only For Investor Use Only Maximizing Immune Integrity Investor Event Presentation July 2023
11:54am
8-K
tlo4un0
17 Jul 23
NKGen Biotech Presents Interim Phase I Trial Data at 2023 Alzheimer’s Association International Conference
8:00am
8-K
bcz 3t8u32wv38pozok
5 Jun 23
Regulation FD Disclosure
8:30am
8-K
p8w 4n2wd
31 May 23
Confidential Confidential Maximizing Immune Integrity Corporate Presentation May 2023
9:45pm
8-K
eyliuzamd86en
22 May 23
Amendments to Articles of Incorporation or Bylaws
9:03pm
8-K
g8vn3 85ctz7aq146
17 Apr 23
Entry into a Material Definitive Agreement
6:01am